Literature DB >> 28325186

Management of Gastroesophageal Junction Tumors.

Ikenna C Okereke1.   

Abstract

Gastroesophageal junction tumors have been increasing in incidence over time, with most tumors presenting at a locally advanced stage. The treatment plan depends on the stage at diagnosis. PET-CT and endoscopic ultrasound are used to determine clinical stage. Depending on the location of the tumor in the esophagus and stomach, treatment can include chemotherapy with or without radiation, followed by surgery if there is no disease progression. Prognosis is related to stage at diagnosis and response to preoperative treatment. Most surgery for gastroesophageal junction tumors can be performed minimally invasively, which helps decrease postoperative length of stay and morbidity from surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Barrett; Minimally invasive; Neoadjuvant

Mesh:

Year:  2017        PMID: 28325186     DOI: 10.1016/j.suc.2016.11.004

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Scaphoid metastasis as the first sign of occult gastroesophageal junction cancer: A case report.

Authors:  Yu-Jie Zhang; Yan-Yan Wang; Qi Yang; Jian-Bing Li
Journal:  World J Clin Cases       Date:  2020-04-06       Impact factor: 1.337

2.  First endoscopic submucosal dissection of gastroesophageal junction carcinoma in a 72-year old male from Saudi Arabia.

Authors:  Abdullah AlShammari; Sreyoshi Fatima Alam; Mohamed Khan; Mohammad Aburahmah
Journal:  Int J Surg Case Rep       Date:  2019-03-05

3.  Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor.

Authors:  Ling-Yu Chu; Jian-Yuan Zhou; Yi-Xuan Zhao; Yan-Ting Ou; Tian Yang; Yu-Hui Peng; Wang-Kai Fang; Yi-Wei Xu; Jian-Jun Xie
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.